Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
WRN RecQ like helicase | 0.524 | 0.808 | 2.6E-34 |
|
group | 0.110 | strong | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
phospholipase D2 | 0.617 | 0.654 | 4.1E-27 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
matrix metallopeptidase 1 | 0.385 | 0.885 | 7.7E-18 |
|
group | 0.020 | None | 1.000 | 1 | 0 | 2002 | 2007 | ||||||||
|
matrix metallopeptidase 9 | 0.305 | 0.923 | 1.9E-17 |
|
group | 0.030 | None | 1.000 | 1 | 0 | 2006 | 2014 | ||||||||
|
FES proto-oncogene, tyrosine kinase | 0.593 | 0.769 | 3.8E-15 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
matrix metallopeptidase 3 | 0.408 | 0.885 | 5.7E-15 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2002 | 2002 | ||||||||
|
piwi like RNA-mediated gene silencing 1 | 0.570 | 0.731 | 7.3E-14 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
ERCC excision repair 5, endonuclease | 0.499 | 0.731 | 2.7E-13 |
|
group | 0.020 | None | 1.000 | 1 | 0 | 2006 | 2012 | ||||||||
|
NKD inhibitor of WNT signaling pathway 2 | 0.729 | 0.192 | 1.5E-12 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
ASPSCR1 tether for SLC2A4, UBX domain containing | 0.653 | 0.538 | 4.4E-12 |
|
group | 0.040 | None | 1.000 | 1 | 0 | 2001 | 2010 | ||||||||
|
methylenetetrahydrofolate reductase | 0.337 | 0.885 | 3.2E-10 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 2008 | 2008 | ||||||||
|
melan-A | 0.579 | 0.692 | 1.3E-09 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2002 | 2002 | ||||||||
|
carbonic anhydrase 9 | 0.483 | 0.731 | 1.3E-09 |
|
group | 0.020 | None | 1.000 | 1 | 0 | 2004 | 2018 | ||||||||
|
CD82 molecule | 0.507 | 0.731 | 1.3E-08 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2007 | 2008 | ||||||||
|
growth hormone releasing hormone receptor | 0.568 | 0.692 | 1.0E-07 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
lymphatic vessel endothelial hyaluronan receptor 1 | 0.587 | 0.731 | 4.7E-07 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
serine/threonine kinase 3 | 0.666 | 0.500 | 6.2E-07 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
plasminogen activator, urokinase | 0.425 | 0.923 | 2.3E-06 |
|
group | 0.020 | None | 1.000 | 1 | 0 | 2007 | 2013 | ||||||||
|
caspase 8 | 0.404 | 0.923 | 3.7E-06 |
|
group | 0.020 | None | 1.000 | 1 | 0 | 2007 | 2015 | ||||||||
|
Ras association domain family member 1 | 0.420 | 0.808 | 4.9E-06 |
|
group | 0.030 | None | 1.000 | 1 | 0 | 2005 | 2012 | ||||||||
|
CD34 molecule | 0.368 | 0.808 | 5.0E-06 |
|
group | 0.050 | None | 1.000 | 1 | 0 | 2006 | 2019 | ||||||||
|
ATP binding cassette subfamily B member 1 | 0.344 | 0.885 | 1.3E-05 |
|
group | 0.100 | None | 0.923 | 1 | 0 | 1991 | 2005 | ||||||||
|
vascular endothelial growth factor A | 0.266 | 0.923 | 2.4E-05 |
|
group | 0.100 | None | 1.000 | 4 | 0 | 2001 | 2018 | ||||||||
|
chondroitin sulfate proteoglycan 4 | 0.599 | 0.615 | 2.6E-05 |
|
group | 0.020 | None | 1.000 | 1 | 0 | 2009 | 2018 | ||||||||
|
cholecystokinin | 0.453 | 0.846 | 3.3E-05 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2004 | 2004 |